Sanofi收购Origimm Biotechnology,率先通过疫苗免疫疗法治疗痤疮

中立 #兼并收购 #Statements#Origimm#Sanofi pipeline#future litigation#skin diseases
来源:www.biospace.com 发表于:2021-12-01
Sanofi to acquire Origimm Biotechnologyin first move to treat acne with vaccine-based immunotherapy Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-as... 原文链接
本文新闻来源www.biospace.com,版权归原作者所有,内容仅代表作者本人观点,不代表企查查的立场。如有任何疑问或需要删除,请联系 kefu@qichacha.com